Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants (KISONKAP)

June 19, 2018 updated by: Nathalie Charpak

Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants Either In Kangaroo Position or in Incubator: A Randomized Control Trial

Kangaroo position (KP), the essential component of the Kangaroo Mother Care (KMC) method, has been increasingly implemented, given the benefits of early skin-to-skin contact on the cerebral maturation of preterm infants. In addition it allows for parents to bond with their infants and humanize the care of fragile infants in neonatal units. Evidence on kinesthetic stimulation (KS) is scarce and currently there is no available evidence on KS during the KP. KS is associated with massage in this paper

Study Overview

Detailed Description

The objective is to study the impact of standardized KS delivered either in KP (KSKP) or in an incubator (KSI) on the early growth of very preterm infants.

Patients and methods: Sixty six newborns ≤32 weeks of gestational age at birth received KS delivered 3 times/day during KP or in an incubator. They were randomized when the infants were considered eligibleto initiate KMC which was part of the routine care for all newborns in the Neonatal Care Unit (NCU). The primary outcome were the weight gain (g/kg/day) between randomization, 5, and 15 days after the start of the intervention and weight at 40 weeks of gestational age (term). The secondary outcomes were the same measures according to the chronological age (days of life) of the infant at randomization.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cundinamarca
      • Bogotá, Cundinamarca, Colombia, 110231
        • Nathalie Charpak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 7 months (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Preterm infants (GA ≤33 weeks of gestation)
  • Deemed clinically stable and eligible for the KMC intervention by the neonatologist were included.

Exclusion Criteria:

  • Infants with congenital anomalies
  • Unstable during the first 15 days of life

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: KS in Kangaroo Position (KSKP)
KS is performed while the infant is in Kangaroo Position using a lycra band to maintain the position.
KSKP was applied daily at regular interval corresponding to the presence of parents. Our protocol is based on the Tiffany Field's protocol with some adjustments corresponding to the constraints of the hospital : the KS was applied 3 times a day and during 15 consecutive days in the hospital or at home and parents were responsible of delivering the intervention. Sunflower oil was used. During the first 5 days, parents performed KSKP with the support of the psychologist. After day 5, parents were expected to perform KSKP by themselves but could ask for help at any moment while in hospital or in the ambulatory follow-up. The KS always began approximately 60 minutes after the feed.
Other Names:
  • KSKP
ACTIVE_COMPARATOR: KS in incubator (KSI)
The infant is in the incubator, unclothed with diaper.
The infant is in the incubator, unclothed with diaper. Parents delivered KSI with the infant in supine position, stroking with the flats of the fingers with moderate pressure. Five 1-minute intervals, consisting of six 10-s periods of stroking, were applied to the following body regions: head, back, both legs and arms. The same process was repeated in prone position. The last part of the intervention was composed of 6 flexions of each extremity.
Other Names:
  • KSI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight gain after randomization up to 5 days
Time Frame: Between randomization and 5 days post randomization
weight gain (g/kg/day)
Between randomization and 5 days post randomization
Weight gain after randomization up to 15 days
Time Frame: Between randomization and 15 days post randomization
weight gain (g/kg/day)
Between randomization and 15 days post randomization
Weight at 40 weeks of gestational age
Time Frame: at 40 weeks of gestational age
Weight in grames
at 40 weeks of gestational age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight gain after randomization up to 5 days if randomization was made before 5 days of chronological age
Time Frame: after randomization up to 5 days if randomization was made before 5 days of chronological age
Weight gain(g/k/d)
after randomization up to 5 days if randomization was made before 5 days of chronological age
Weight gain after randomization up to 15 days if randomization was made before 5 days of chronological age
Time Frame: after randomization up to 15 days of chronological age if randomization was made before 5 days of chronological age
Weight gain(g/k/d)
after randomization up to 15 days of chronological age if randomization was made before 5 days of chronological age
Weight at 40 weeks if randomization was made before 5 days of chronological age
Time Frame: at 40 weeks of gestational age if randomization was made before 5 days of chronological age
Weight in grames
at 40 weeks of gestational age if randomization was made before 5 days of chronological age
Weight gain after randomization up to 5 days if randomization was made between 6 and 10 days of chronological age
Time Frame: after randomization up to 5 days if randomization was made between 6 and 10 days of chronological age
Weight gain(g/k/d)
after randomization up to 5 days if randomization was made between 6 and 10 days of chronological age
Weight gain after randomization up to 15 days if randomization was made between 6 and 10 days of chronological age
Time Frame: after randomization up to 15 days if randomization was made between 6 and 10 days of chronological age
Weight gain(g/k/d)
after randomization up to 15 days if randomization was made between 6 and 10 days of chronological age
Weight at 40 weeks if randomization was made between 6 and 10 days of chronological age
Time Frame: at 40 weeks of gestational age if randomization was made between 6 and 10 days of chronological age
Weight in grames
at 40 weeks of gestational age if randomization was made between 6 and 10 days of chronological age
Weight gain after randomization up to 5 days if randomization was made more than 10 days of chronological age
Time Frame: after randomization up to 5 days if randomization was made more than 10 days of chronological age
Weight gain(g/k/d)
after randomization up to 5 days if randomization was made more than 10 days of chronological age
Weight gain after randomization up to 15 days if randomization was made more than 10 days of chronological age
Time Frame: after randomization up to 15 days if randomization was made more than 10 days of chronological age
Weight gain(g/k/d)
after randomization up to 15 days if randomization was made more than 10 days of chronological age
Weight at 40 weeks if randomization was made more than 10 days of chronological age
Time Frame: at 40 weeks of gestational age if randomization was made more than 10 days of chronological age
Weight in grames
at 40 weeks of gestational age if randomization was made more than 10 days of chronological age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea C Aldana Acosta, PhD, Universidad Piloto de Colombia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 15, 2013

Primary Completion (ACTUAL)

August 30, 2016

Study Completion (ACTUAL)

February 28, 2018

Study Registration Dates

First Submitted

June 4, 2018

First Submitted That Met QC Criteria

June 19, 2018

First Posted (ACTUAL)

July 2, 2018

Study Record Updates

Last Update Posted (ACTUAL)

July 2, 2018

Last Update Submitted That Met QC Criteria

June 19, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurobehavioral Manifestations

Clinical Trials on KS in Kangaroo Position

Subscribe